Investments

News & Insights

About Us

Contact Us

Top Banner

Company Interview / Complii capitalises on compliance push

Loading

Preparing video

Complii capitalises on compliance push

Company Interview27 Aug, 2025

Key bullet points:

Complii Fintech Solutions reports 29% group revenue growth to $8.13 million in FY25Expansion into Canada and the UK driven by regulatory similarities and client demandClients raised $11.1 billion through the platform as market activity improvesAI adoption is focused on efficiency but tempered by compliance considerations

Complii Fintech Solutions (ASX: CF1) has reported robust financial growth for FY25, with group revenue rising 29% to $8.13 million. Craig Mason attributes this performance to continued business development in the compliance space, strong execution of strategy, and a focus on improving IRR despite challenging global market conditions. The company’s divestment of Predatory Direct is cited as a positive move for its balance sheet, while ongoing commitment to client collaboration remains central. Mason notes that recent transactions have helped to reinforce the company’s operational direction.

Mason highlights Complii Fintech Solutions’ expansion of its capital raising solution into Canada and the UK, linking this to the strong similarities in regulatory frameworks across these Western markets. He points out that clients, such as Canaccord and New Horizons, already operate internationally, motivating the company’s push into these regions. Mason observes growing inbound demand from both Canada and the UK, suggesting that cross-border opportunities are increasingly tangible, although entry into new markets will remain customer-driven.

Locally, Mason notes a recent uptick in capital raisings, with clients raising $11.1 billion across the platform in FY25. He credits market momentum and regulatory developments, such as ASIC’s faster IPO reviews, with contributing to this positive shift. Mason also sees AI increasing efficiency for compliance, but maintains a cautious approach given regulatory priorities.

Copyright © 2025 Ausbiz Capital